Cite

    Poornima Varma et al.. “Immunomodulator use does not prevent first loss of response to anti‐tumour necrosis factor alpha therapy in inflammatory bowel disease: long‐term outcomes in a real‐world cohort.” Internal medicine journal, vol. 49, no. 6, 2019, pp. 753–760. http://access.bl.uk/ark:/81055/vdc_100086191805.0x00001c